INS and diabetes mellitus: This severe metabolic complication is typically associated with Type 1 diabetes mellitus (T1DM), as a first presentation or as a consequence of non-optimal insulin therapy management; however, it can occasionally affect Type 2 diabetes mellitus (T2DM) patients.